Establishes the NIH INCLUDE Project to coordinate and expand research, trials, and training focused on Down syndrome and related conditions.
The bill promotes coordinated research, trials, and recognition that can improve care, training, and social inclusion for people with Down syndrome, but it does not guarantee immediate services, requires additional funding, and raises risks around resource trade-offs and privacy.
People with Down syndrome (and their families) will gain more targeted research and clinical trials that are likely to improve diagnosis, treatments, and health outcomes.
Families of individuals with Down syndrome will benefit from research-backed quality-of-life improvements and expanded support services informed by new studies and evidence.
Clinicians, health systems, and researchers will gain usable real-world evidence, funding, training, and technical assistance that can improve clinical decision-making and build scientific capacity focused on chromosome 21 biology and related conditions.
The bill's findings and research initiatives do not by themselves create new services or guaranteed funding, so families may see no immediate practical benefits without follow-up appropriations or implementing programs.
Focusing research and funds on Down syndrome could divert NIH resources and attention from other conditions if overall budgets are not increased, potentially disadvantaging other patient groups and researchers.
Assembling and sharing large real-world datasets raises privacy and consent challenges that could put personal health information of people with Down syndrome and related patients at risk if not carefully managed.
Based on analysis of 3 sections of legislative text.
Official title: Amend the Public Health Service Act to authorize the Secretary of Health and Human Services to carry out a program of research, training, and investigation related to Down syndrome, and for other purposes.
Introduced May 21, 2025 by John Wright Hickenlooper · Last progress August 10, 2026
Creates a new NIH program called the INCLUDE Project to expand research, training, clinical trials, and coordination focused on Down syndrome. The law directs NIH to carry out studies of chromosome 21 biology, co-occurring health conditions, biomarkers, and interventions, and to coordinate across institutes and report biennially to Congress on supported research and outcomes. The program may use grants, contracts, and intramural work, must avoid duplicative efforts, provide technical assistance to awardees, and prioritize large, inclusive study populations and quality-of-life research to improve care for people with Down syndrome and related conditions.